Picard Medical (PMI) Fundamental Analysis: Revenue, Earnings & Valuation

1.05 / 10

Underperform

Fundamental rating is Underperform with a 1.1/10 quality score. Cash‑UP and net‑profit ratio are the only modest positives; cash‑MV, ROA, ROE and profit‑MV are negative, indicating weak financial health.

Analysis Checks(2/10)

ROA (%)

Value-177.24

Score0/3

Weight13.22%

1M Return-6.12%

Annualized return on equity (%)

Value-47.90

Score1/3

Weight5.99%

1M Return-2.02%

Profit-MV

Value0.68

Score1/3

Weight15.21%

1M Return-5.93%

Cash-UP

Value-0.16

Score2/3

Weight11.02%

1M Return-3.92%

Annualized net profit margin on total assets (%)

Value-236.32

Score0/3

Weight13.22%

1M Return-6.12%

ROE (diluted) (%)

Value-285.03

Score0/3

Weight13.27%

1M Return-5.82%

Asset-MV

Value-0.55

Score0/3

Weight9.68%

1M Return-3.34%

ROE (%)

Value-35.92

Score1/3

Weight5.99%

1M Return-2.02%

Cash-MV

Value0.03

Score1/3

Weight9.50%

1M Return-3.56%

Net profit / Total profit (%)

Value100.14

Score2/3

Weight2.89%

1M Return-0.89%

Is PMI undervalued or overvalued?

PMI scores 1.05/10 on fundamentals and holds a Premium valuation at present. Backed by its 0.00% ROE, -661.82% net margin, -2.53 P/E ratio, 9.62 P/B ratio, and 0.00% earnings growth, these metrics solidify its Underperform investment rating.